A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Therapeutic Advantage of Anti-VAP-1 Over Anti-alpha 4 Integrin Antibody in Concanavalin A-Induced Hepatitis
Tekijät: Lee WY, Salmi M, Kelly MM, Jalkanen S, Kubes P
Kustantaja: WILEY-BLACKWELL
Julkaisuvuosi: 2013
Journal: Hepatology
Tietokannassa oleva lehden nimi: HEPATOLOGY
Lehden akronyymi: HEPATOLOGY
Numero sarjassa: 4
Vuosikerta: 58
Numero: 4
Aloitussivu: 1413
Lopetussivu: 1423
Sivujen määrä: 11
ISSN: 0270-9139
DOI: https://doi.org/10.1002/hep.26469
Tiivistelmä
Hepatitis induced by concanavalin A (Con A) in mice is well known to be a T-lymphocyte-mediated injury. It has been reported that T helper (Th)1 and Th2 lymphocytes use 4 integrin and vascular adhesion protein (VAP)-1, respectively, to adhere within the hepatic sinusoids. Therefore, we investigated whether inhibition of these molecules ameliorates or worsens the Con A-induced hepatic injury in vivo. Vehicle or antibody to 4 integrin or VAP-1 was intravenously administered 30 minutes before Con A administration. In control mice Con A markedly increased the serum alanine aminotransferase (ALT) level in a dose-dependent manner, and induced a massive infiltration of CD3, particularly interleukin (IL)-4 producing CD4 T cells and liver injury. Both parameters were reduced by anti-VAP-1 antibody despite antibody only blocking the adhesion, not the amine oxidase activity of VAP-1. Both activities of VAP-1 were eliminated in VAP-1-deficient mice and both Con A-induced liver injury and CD4 T-cell infiltration were eradicated. In contrast to anti-VAP-1, anti-4 integrin antibody reduced interferon-gamma (IFN-)-producing CD3 T cells but this worsened Con A hepatitis, suggesting inhibition of a suppressor cell. Con A induced the recruitment of CD49d(+) monocytic myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs) into the liver. Anti-4 integrin dramatically blocked the influx of MDSCs but not Tregs. Conclusion: Our findings show that VAP-1 and 4 integrin have opposing effects in Con A-induced hepatic injury, which is associated with blocking the recruitment of CD4 lymphocytes and monocytic MDSCs, respectively. Moreover, these data provide the rationale for a potential therapeutic approach to target adhesion molecules in autoimmune hepatitis. (Hepatology 2013;58:1413-1423)
Hepatitis induced by concanavalin A (Con A) in mice is well known to be a T-lymphocyte-mediated injury. It has been reported that T helper (Th)1 and Th2 lymphocytes use 4 integrin and vascular adhesion protein (VAP)-1, respectively, to adhere within the hepatic sinusoids. Therefore, we investigated whether inhibition of these molecules ameliorates or worsens the Con A-induced hepatic injury in vivo. Vehicle or antibody to 4 integrin or VAP-1 was intravenously administered 30 minutes before Con A administration. In control mice Con A markedly increased the serum alanine aminotransferase (ALT) level in a dose-dependent manner, and induced a massive infiltration of CD3, particularly interleukin (IL)-4 producing CD4 T cells and liver injury. Both parameters were reduced by anti-VAP-1 antibody despite antibody only blocking the adhesion, not the amine oxidase activity of VAP-1. Both activities of VAP-1 were eliminated in VAP-1-deficient mice and both Con A-induced liver injury and CD4 T-cell infiltration were eradicated. In contrast to anti-VAP-1, anti-4 integrin antibody reduced interferon-gamma (IFN-)-producing CD3 T cells but this worsened Con A hepatitis, suggesting inhibition of a suppressor cell. Con A induced the recruitment of CD49d(+) monocytic myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs) into the liver. Anti-4 integrin dramatically blocked the influx of MDSCs but not Tregs. Conclusion: Our findings show that VAP-1 and 4 integrin have opposing effects in Con A-induced hepatic injury, which is associated with blocking the recruitment of CD4 lymphocytes and monocytic MDSCs, respectively. Moreover, these data provide the rationale for a potential therapeutic approach to target adhesion molecules in autoimmune hepatitis. (Hepatology 2013;58:1413-1423)
Turun yliopiston Tutkimustietojärjestelmän portaali